Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know

{# Share Buttons Partial Variables: share_title — text to pre-fill in share dialogs share_url — canonical URL to share (use request.build_absolute_uri in parent) #}

Market Intelligence Analysis

AI-Powered
Why This Matters

Shares of Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna plummeted in the afternoon session due to escalating U.S.-Iran conflict uncertainty and policy deadlines set by the Trump administration, contributing to a broader market sell-off. The S&P 500 and Dow Jones Industrial Average also fell sharply. This event may lead to a risk-off environment, potentially affecting various asset classes.

Market Impact

The decline in these stocks, particularly in the healthcare and biotech sectors, may lead to a sector-wide sell-off, with potential cross-market reflections in other risk assets. The sharp fall in major indices like the S&P 500 and Dow Jones Industrial Average could amplify the downward move in these stocks, with Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna being directly affected, with potential losses of 5-10% or more.

Sentiment
Bearish
AI Confidence
80%
Time Horizon
Short Term

Article Context

Note: This is a brief excerpt for context. Click below to read the full article on the original source.

A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as investors reacted to escalating uncertainty tied to the U.S.-Iran conflict and policy deadlines set by the Trump administration.

Continue Reading
Full article on Yahoo Finance
Read Full Article
Original article published by Yahoo Finance on March 27, 2026.
Analysis and insights provided by AnalystMarkets AI.